Opaleye Management’s Elevation Oncology ELEV Stock Holding History

Opaleye Management’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,442,061	Closed	-$529K	–	47
2025 Q2	$529K	Buy	+1,442,061	New	+$481K	0.11%	38

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Opaleye Management's ELEV Position: Q3 2025 in Review

Opaleye Management sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 1,442,061 shares — an estimated $529K sold.

Opaleye Management first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $529K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Opaleye Management reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Opaleye Management sold 1,442,061 Elevation Oncology shares in Q3 2025, an estimated $529K.
Opaleye Management first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Opaleye Management's Elevation Oncology position peaked at $529K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Opaleye Management's 13F filing for Q3 2025, filed 14 Nov 2025.